The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 5.0 Trial Academy 2021
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Missouri Court of Appeals Affirms $38M Depakote Verdict

Posted on November 17, 2016 by Larry Bodine
John Eddie Williams, Jr., Managing Partner of the Williams Kherkher law firm.

John Eddie Williams, Jr., Managing Partner of the Williams Kherkher law firm.

The Missouri Court of Appeals, Eastern District, upheld Houston-based trial firm Williams Kherkher’s $38 million dollar verdict against Abbott Labs for failing to provide accurate information to doctors regarding the use of the anti-epilepsy drug Depakote.

Depakote, the proprietary name given to the drug divalproex sodium in the United States, is a prescription drug that was developed to treat seizures and episodes of mania for those with bipolar disorder. While Depakote served as an effective treatment for some ailments and disorders, it has also been linked to serious side-effects that can cause lasting health problems.

The verdict was obtained by attorneys John Eddie, John Boundas, Sejal Brahmbhatt, Margot Trevino, and Brian Abramson of Williams Kherkher in Houston, TX.

Omitting drug’s dangers

According to the November 08, 2016 court opinion: “The evidence and testimony set forth at trial exposed to the jury [Abbott’s] knowledge of the current data about Depakote, and the numbers in the form of profits [Abbott] reaped by willfully omitting the extent of the drug’s dangers from its warning to doctors to protect its profits.

“The jury could clearly deduce from this evidence that explicit, accurate, and up-to-date warnings were sacrificed in the name of profits at [Abbott], and further, [Abbott] intentionally deceived and distorted the truth about Depakote to doctors depriving them of the ability to have all the necessary information to make a considered medical decision as to whether to prescribe the drug.”

“The jury heard evidence [Abbott’s] focus on profit motivated it to conceal the serious hazards presented by Depakote to women of childbearing potential. [Abbott] spent $50-100 million per year marketing Depakote, yet spent no money on conducting independent safety research. Senior executives wanted market share to increase versus its competitors and thus endorsed and compelled the sales and marketing strategy of promoting Depakote’s first-line use in women even though it was known to be a dirty drug whose use should be the last resort among AEDs in childbearing women.”

The $38 million verdict upheld by the appellate court included $23 million dollars in punitive damages.  The appellate court found that rather than acting in the best interests of its customers, the company showed a blatant disregard for public health and unethically worked to increase its profits at the expense of women who needed help coping with various conditions and their unborn children.

Williams Kherkher is a nationally recognized trial law firm, representing clients across the country in mass torts, personal injury and commercial litigation. Williams Kherkher welcomes the opportunity to work with other law firms in joint ventures.

Posted in Blog, Personal Injury

Comments are closed.

News Categories

Subscribe to Blog and VFJ via Email

Enter your email address to subscribe to this blog, the Voice for Justice and receive notifications of new posts by email.

Read about other Top Jury Verdicts

Intel Ordered to Pay a $2.2B Settlement in Patent Infringement Case

Intel Ordered to Pay a $2.2B Settlement in Patent Infringement Case

Intel was told to pay $2.18 billion after losing a patent-infringement trial over technology related to chip-making.Intel inf[Read More...]
What is Sexual Harassment?

What is Sexual Harassment?

Sexual Harassment Defined: Legally, sexual harassment is a form of sex discrimination that violates Title VII of the [Read More...]
Facebook Pays $650M to Settle a Privacy Dispute

Facebook Pays $650M to Settle a Privacy Dispute

WASHINGTON: A US federal judge has given final approval to Facebook's US$650 million payment to settle a privacy dispute betw[Read More...]
Pharmaceutical Giant Johnson & Johnson is Preparing $3.9B for Talc Settlements

Pharmaceutical Giant Johnson & Johnson is Preparing $3.9B for Talc Settlements

Pharmaceutical giant Johnson & Johnson has set aside $3.9 billion for talc-related litigation, according to a regulatory [Read More...]
Alaska Airlines Will Pay $3.19M Following the Death of a Passenger

Alaska Airlines Will Pay $3.19M Following the Death of a Passenger

Seattle-based Alaska Airlines has been ordered to pay more than $3 million to the family of a passenger of reduced mobility w[Read More...]

#LegalNews

@@TheNTLtop100

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.